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Nursing homes represent a unique and important methicillin-resistant Staphylococcus aureus (MRSA) reservoir. Not only are
strains imported from hospitals and the community, strains can be transported back into these settings from nursing homes.
Since MRSA bacteria are prevalent in nursing homes and yet relatively poorly studied in this setting, a multicenter, regional as-
sessment of the frequency and diversity of MRSA in the nursing home reservoir was carried out and compared to that of the
MRSA from hospitals in the same region. The prospective study collectedMRSA from nasal swabbing of residents of 26 nursing
homes in Orange County, California, and characterized each isolate by spa typing. A total of 837MRSA isolates were collected
from the nursing homes. Estimates of admission prevalence and point prevalence of MRSA were 16% and 26%, respectively. The
spa type genetic diversity was heterogeneous between nursing homes and significantly higher overall (77%) than the diversity in
Orange County hospitals (72%). MRSA burden in nursing homes appears largely due to importation from hospitals. As seen in
Orange County hospitals, USA300 (sequence type 8 [ST8]/t008), USA100 (ST5/t002), and a USA100 variant (ST5/t242) were the
dominant MRSA clones in Orange County nursing homes, representing 83% of all isolates, although the USA100 variant was
predominant in nursing homes, whereas USA300 was predominant in hospitals. Control strategies tailored to the complex prob-
lem of MRSA transmission and infection in nursing homes are needed in order to minimize the impact of this unique reservoir
on the overall regional MRSA burden.
Methicillin-resistant Staphylococcus aureus (MRSA) is a majorcause of morbidity and mortality worldwide and has signif-
icant economic consequences (1–6). Residence in a nursing home,
which typically provides long-term care for chronically ill and/or
elderly people, is a well-established risk factor for MRSA carriage
and infection (7–10), and MRSA carriage in nursing home resi-
dents is associated with increased mortality (11). Nursing homes
represent a unique and important MRSA reservoir, as patients
colonized with MRSA tend to introduce the organism into nurs-
ing homes from the hospital setting, and MRSA can also be trans-
ported back into hospitals and the community from the nursing
home. A recent modeling study demonstrated that nursing homes
play an important role in regional MRSA transmission dynamics
(12). The reservoir represented by colonized patients is often large
due to the high MRSA prevalence in nursing homes, sometimes
higher than 30%, which increases the risk of MRSA transmission
in these facilities (10, 13–15). Furthermore, once colonized, nurs-
ing home residents seem to carry the same MRSA strain for pro-
longed periods of time; asymptomatic colonization has been re-
ported to last from 3 months to 3 years (16, 17). Studies suggest
that multiple strains circulate within nursing homes (10, 16, 18).
Not only does the complex operational structure of nursing
homes, which act as both a health care setting and a resident’s
home, make it difficult for standard MRSA control practices to be
implemented, but a standardized MRSA control strategy for nurs-
ing homes is yet to be agreed on, largely due to the lack of studies
aimed at identifying appropriate strategies (19). There is also a
general dearth of studies, particularly regional ones, investigating
the makeup of the nursing home MRSA reservoir. A study of 60
nursing homes in Belgium identified hospital care, comorbidities,
and a lack of coordinated MRSA surveillance and control activities
as risk factors for MRSA carriage in nursing home residents (20).
A study of 32 nursing homes in northern Germany listed indwell-
ing devices, wounds, preceding hospital admission, and high-
grade resident care as risk factors for carriage (21). Both studies
found that the predominant MRSA strains among nursing home
residents were identical to those found in hospital inpatients,
highlighting the need for synergistic infection control between
nursing homes and hospitals (20, 21). A better understanding of
the frequency and diversity of nursing home MRSA strains and
predictors thereof will help to form strategies for minimizing
MRSA transmission and infection in nursing homes, and thus
reduce the impact of the nursing home MRSA reservoir on hospi-
tals.
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Assessing the extent to which traditionally community-associ-
ated MRSA (CA-MRSA) has penetrated the nursing home reser-
voir is also of interest. CA-MRSA has become increasingly domi-
nant in recent years, and the MRSA clone USA300 in particular
has several characteristics that may offer a selective advantage over
the traditional health care-associated MRSA (HA-MRSA), includ-
ing higher transmissibility and increased pathogenicity (22, 23).
There is also growing evidence from several countries, particularly
the United States, that community and health care reservoirs are
mixing (24–30).
We conducted a prospective study of MRSA isolates in nursing
home residents in a large U.S. metropolitan county to investigate
the frequency and genetic diversity of MRSA in these facilities, and
thus gain a better understanding of the nature of the nursing home
MRSA reservoir.
MATERIALS AND METHODS
Study design. We conducted a population-based prospective study of
nares colonization isolates of MRSA from 26 nursing homes in Orange
County, California. This study was approved by the Institutional Review
Board of the University of California Regents, and a waiver of informed
consent was granted.
Isolate collection. Carriage isolates of MRSA from unique residents
were collected from participating nursing homes between January 2009
and April 2011. Each nursing home was instructed to swab the nares of
100 consecutive residents upon admission (within 3 days of arrival) and
100 residents on a single day (point prevalence screening) using bilateral
nares swabs (BD Culture Swabs; Fisher Scientific). For nursing homes
with a low bed turnover, fewer residents were screened (30–50). For nurs-
ing homes with an average length of stay in years, admission screening was
not performed. Swabs were cultured for MRSA using selective medium
(BD CHROMagar). MRSA strains were stored at65°C in brucella broth
containing 15% glycerol.
Specimen data and nursing home characteristics. Specimen data,
including swab type (admission or point prevalence), swab day since ad-
mission, room type (shared or single resident room), and whether the
swabbed resident had prior MRSA, were collected. Demographic, func-
tional status, and comorbidity data for participating nursing homes were
derived from the Centers for Medicare and Medicaid Services (CMS)
Long Term Care Minimum Data Set for 2009 (http://www.resdac.org
/MDS/data_available.asp; last accessed 10 April 2012) and included an-
nual admissions and the percentage of residents with the following char-
acteristics: 65 years of age; male; nonwhite; Hispanic; education less
than high school level; admitted from a hospital; history of MRSA, diabe-
tes, fecal incontinence, skin lesions, and medical devices (which included
tracheostomy, ventilator, and dialysis devices).
Laboratory methods and molecular typing. All laboratory methods
and molecular typing (spa typing, multilocus sequence typing [MLST],
and SmaI pulsed-field gel electrophoresis [PFGE]) were performed as
described previously (30). spa typing was performed on all collected iso-
lates. MLST was performed on a subset of isolates (n  138), and the
combination of MLST and spa typing information was used to infer strain
types and major U.S. MRSA clones (USA100, USA300, etc.). This subset
included one isolate of each spa type so that all spa types were represented,
and for the 10 most common spa types, one isolate from each of the
hospitals in which these spa types were present. Isolates were selected by
using a random number generator.
Definitions. Throughout this study the terms “traditionally CA-
MRSA” and “traditionally HA-MRSA” were used to emphasize that, while
certain clones were originally identified as community- or health care-
associated clones, such clones may well be present and/or established in
both settings today. We used this terminology in order to more clearly
evaluate any mixing of MRSA reservoirs.
Statistical analyses. The median and interquartile range (IQR) were
calculated for each variable. One- and two-sample z-tests for equality of
proportions were conducted to compare the number of isolates belonging
to spa types t008 and t002/t242 within each nursing home, the number of
t002 and t242 isolates within each nursing home, and overall MRSA car-
riage at admission versus MRSA point prevalence. Simpson’s index of
diversity (1  D) was used to estimate inter- and intra-nursing home
genetic diversity of the MRSA strains collected, as well as the genetic di-
versity of the two major spa clonal complexes (spa-CCs) and genetic di-
versity among admission and point prevalence isolates. Simpson’s index
of diversity provides an unbiased measure of the probability of drawing
two different spa types given the distribution of spa types in a sample (31).
Confidence intervals (95% confidence intervals [95% CIs]) were calcu-
lated as described previously (32). For comparison of diversity indices, a
significant difference (P 0.05) was determined by nonoverlapping 95%
CIs. 2 tests compared the proportion of isolates belonging to spa types
t008 and t002/t242 between nursing homes and between MRSA admis-
sion and point prevalence isolates. Pearson’s correlation coefficients were
computed to determine the relationships between nursing home variables
and genetic diversity and between isolate variables and genetic diversity.
Due to the small sample size of nursing homes (21 nursing homes in-
cluded; of the 26 nursing homes, one did not isolate any MRSA, and four
were excluded in this analysis, as they collected10 MRSA isolates) and
the number of potential predictor variables for genetic diversity, variables
were considered for entry into a bootstrapped multiple linear regression
model based on a combination of their correlation coefficient and current
knowledge regarding their association with MRSA. Only variables with
P 0.1 in correlation tests were considered for the exploratory model. All
statistical tests were performed using STATA (release 11, StataCorp 2009).
RESULTS
Between January 2009 and April 2011, 3,806 nasal swabs were
taken from residents of 26 nursing homes in Orange County, Cal-
ifornia, either on admission or for estimating MRSA point preva-
lence. Of these, 837 swabs (22%) isolated MRSA. The overall ad-
mission prevalence for the 26 nursing homes was 16%, and point
prevalence was significantly higher at 26% (P 0.001). One nurs-
ing home did not isolate any MRSA and was not considered fur-
ther.
The majority of the 837 MRSA isolates were from point prev-
alence testing (68%), from residents with no history of MRSA
(76%), and from residents sharing a room (95%). The median
number of days from admission to swab collection was 53 (IQR, 4
to 265). A third of all admission swabs were collected at day 4 since
some nursing homes could not swab earlier. Tables 1 and 2 give a
summary overview of the 26 nursing homes and isolate character-
istics.
spa typing andMLST.Of the 837 MRSA isolates collected, 835
were spa typed. Two isolates could not be spa typed, as one did not
grow upon culturing and a spa PCR product was not obtained
from the other. Among the 835 MRSA isolates, 60 spa types were
identified, including nine spa types (1.4% of all isolates) that did
not match any known spa sequence. These novel spa sequences
were automatically submitted to the Ridom SpaServer via the Ri-
dom StaphType software and were assigned new spa types. One
isolate that was nontypeable (NT) by spa typing was identical to
spa type t002, except for two extra nucleotides in the third repeat,
making the repeat 26 bp long and putting the spa coding region
out of frame. This isolate was retested to confirm that the result
was not due to a processing error, and the spa type sequence was
submitted to Ridom for their records. A clinical MRSA isolate
from a patient in a hospital in Orange County, California, was
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similarly NT, and others have reported spa repeats of unexpected
length (J. Rothganger, Ridom GmbH, personal communication)
(29). The three most common spa types were t242, t008, and t002,
representing 83% of all isolates collected (Table 3). The remaining
57 spa types each represented 1.4% or less of all isolates (Table 3;
see Table S1 in the supplemental material).
BURP (based upon repeat pattern) analysis of the spa types
clustered 94% of isolates into two large spa clonal complexes (spa-
CCs) and 3% of isolates into two smaller spa-CCs (Fig. 1). Half of
all spa types were clustered into spa-CC002 (predicted founder
t002) and 20% into spa-CC008 (founder t008), including six novel
spa types and one novel spa type, respectively. Using the BURP
algorithm, spa types that differ from all other spa types in the
sample by more than four repeats cannot reasonably be clustered
into a spa-CC and are termed singletons. Ten spa types (17 iso-
lates) were classed as singletons, including one novel spa type. Two
isolates representing two spa types (t026 and t8606) were less than
five repeats in length and were excluded from BURP analysis,
because no reliable evolutionary history can be inferred from
“short” spa types (33). The NT isolate could also not be included
in the BURP algorithm. The estimated genetic diversity of MRSA
in nursing homes in Orange County, California, using spa typing
was high, at 77% (Table 3). The diversity of spa types among
spa-CC008 isolates (1  D  23% [95% CI, 12 to 33%]) was
significantly lower than the diversity among spa-CC002 isolates
(1 D 60% [95% CI, 58 to 63%]).
To confirm strain types, 138 isolates were selected for MLST.
Among the 15 unique sequence types (STs) identified, ST5 (54%)
and ST8 (28%) were the most predominant, with the majority of
isolates belonging to one of two major MLST CCs: CC5 (60%; five
STs) and CC8/239 (29%; two STs) (Table 4). According to MLST,
t008 isolates were ST8, and t002 isolates were ST5. t242 isolates
were also identified as ST5 (Tables 3 and 4). While PFGE was not
performed on the nursing home isolates, previous PFGE testing of
Orange County MRSA isolates has shown that t008/ST8 isolates
were the prototypic community clone USA300, and t002/ST5 and
t242/ST5 isolates were predominantly the prototypic hospital
clone USA100 (29, 30). spa type t242 differs from t002 by one spa
repeat, as a result of a single-nucleotide difference. The NT spa
isolate and one novel, singleton spa type were ST105, with seven of
the other novel spa types being ST5 (78%) and one being ST8
(11%).
Nursing homedifferences. Four nursing homes collected10
MRSA isolates, and the MRSA genetic diversity could not be reli-
ably estimated. For the 21 remaining nursing homes, the genetic
diversity of MRSA ranged from 43% to 84% (Fig. 2). Genetic
diversity was positively correlated with the percentage of residents
admitted from a hospital (r 0.52; P 0.02), percentage of res-
idents with diabetes (r 0.57; P 0.01), percentage of residents
with skin lesions (r  0.46; P  0.03), MRSA admission preva-
lence (r 0.50; P 0.03), and MRSA point prevalence (r 0.47;
P 0.03). Genetic diversity within nursing homes was negatively
correlated with the percentage of residents under 65 years old (r
0.57; P 0.01) and the percentage of male residents (r0.43;
P 0.05).
The percentage of residents with skin lesions was positively
correlated with the percentage of residents admitted from a hos-
pital (r 0.84; P 0.001). The percentage of residents with skin
lesions showed weaker correlation with genetic diversity and thus
was not considered for entry into the bootstrapped linear regres-
sion model. Similarly, the percentage of male residents and the
percentage of residents under 65 were highly correlated (r 0.88;
P  0.001). Since age was more strongly correlated with genetic
diversity than gender and differences in MRSA strain types have
been observed between age groups in a previous study (30), the
percentage of male residents was not considered for entry into the
TABLE 2 Summary of characteristics of the 837 MRSA carriage isolates
from nursing home residents in Orange County, California
Characteristic
No. of isolates (%)
Total MRSA t008 t242 t002
Total 837 222 (26.5) 273 (32.6) 195 (23.3)
Admission 269 (32.1) 64 (23.8) 90 (33.5) 69 (25.7)
Point prevalence 568 (67.9) 158 (27.8) 183 (32.2) 126 (22.2)
Resident has history
of MRSA
201 (24.0) 53 (26.4) 58 (28.9) 58 (28.9)
Resident living in
shared room
795 (95.0a) 219 (27.5) 257 (32.3) 179 (22.5)
a 92.6% of all swabbed patients shared a room.
TABLE 3 Ten most frequently found spa types among MRSA isolates
from residents of nursing homes in Orange County, Californiaa
Rank spa type MLSTb Frequency % Cumulative %
1 t242 5 273 32.7 32.7
2 t008 8 222 26.6 59.3
3 t002 5 195 23.4 82.6
4 t127 474 12 1.4 84.1
5 t306 5 11 1.3 85.4
6 t088 105 10 1.2 86.6
7 t037 239 7 0.8 87.4
8 t024 8 6 0.7 88.1
9 t068 8 6 0.7 88.9
10 t548 5 6 0.7 89.6
Other 87 10.4 100.0
a The total number of spa types was 60, including one nontypeable isolate. Simpson’s
index of diversity (1 D) value was 77% (95% CI, 75% to 78%). This table is based
upon the results of 835 MRSA isolates, since two isolates were nontypeable by spa
typing.
b MLST, multilocus sequence type.
TABLE 1 Summary of characteristics of the 26 participating nursing
homes in Orange County, California
Characteristic Median value (IQR valuea)
Annual no. of admissions 263 (138–520)
% residents of65 years of age 22.5 (4–40)
% male 42.2 (31.6–50.3)
% education less than high school level 23.9 (7.4–34.1)
% Hispanic residents 14.3 (3.7–23)
% nonwhite residents 15.7 (7.8–21.8)
% residents admitted from a hospital 81.9 (56.6–93.8)
% residents with diabetes 26.9 (22.7–42.1)
% residents with fecal incontinence 42.2 (26.4–54.8)
% residents with skin lesions 72.2 (50–86.5)
% residents with devices 2.2 (1.2–7.1)
% residents with MRSA history 11.5 (6–19)
MRSA admission prevalence 16 (11–22)
MRSA point prevalence 26.3 (16–34)
No. of spa types per nursing home 5 (4–8)
a IQR, interquartile range.
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multiple regression model. Finally, point prevalence was highly
correlated with admission prevalence (r 0.74; P 0.001); there-
fore, only admission prevalence was considered for regression
model entry due to its slightly stronger correlation with genetic
diversity. Only the percentage of residents aged 65 or over and the
percentage of diabetic residents remained significant predictors of
spa type genetic diversity in the exploratory regression model (co-
efficient0.22, bootstrap standard error 0.06, normal-based
95% CI0.35 to0.10, and P 0.01 and coefficient 0.41,
bootstrap standard error 0.10, normal-based 95% CI 0.22 to
0.60, and P 0.001, respectively).
Two nursing homes isolated t008 only, although the sample
sizes were 10. For the other 23 nursing homes, the three most
common spa types—t242, t008, and t002—accounted for 55 to
96% of isolates, showing that these spa types are consistently dom-
inant across nursing homes in Orange County, California (see
Table S1 in the supplemental material). spa type t242 was domi-
nant in 12 nursing homes (36 to 63% of isolates).
The proportion of t008 (USA300) isolates compared to t002/
t242 (USA100) isolates varied significantly between nursing
homes (2  85.0; df  24; P  0.001) (Fig. 2). Two nursing
homes (8%) had significantly more t008 (USA300) isolates, and
18 nursing homes (72%) had significantly more t002/t242
(USA100) isolates (P 0.05). Of the t002/t242 isolates, 10 (40%)
FIG 1 Relatedness of spa types among nursing home MRSA isolates. Relatedness was computed using the BURP (based upon repeat pattern) algorithm. Clusters
of linked spa types correspond to spa clonal complexes (spa-CCs). spa types are clustered into a spa-CC when their repeat patterns differ by no more than 4
repeats. The BURP algorithm sums up “costs” (a measure of relatedness based on the repeat pattern) to define a founder score for each spa type in a spa-CC. The
founder (blue node) is the spa type with the highest founder score in its spa-CC, and the subfounder (yellow node) is the spa type with the second highest founder
score. spa-CC008 has founder t008, and spa-CCNF refers to a spa-CC with no founder. Each node represents a spa type. Node size represents the number of
clustered strains that belong to that spa type. The shading of the branches represents the “costs” (similarities in repeat patterns) between two spa types; the darker
the branch, the lower the cost (more similar repeat patterns).
TABLE 4 Relatedness of STs of 138 nursing home MRSA isolates
according to eBURST algorithma
CC (no. of isolates)b ST Associated spa type(s)c
CC5 (83) 5 t002, t242, t306, 28 others
105 t088, t002, t8444
221 t002
1011 t895
1510 t242
CC8/239 (40) 8 t008, t024, 12 others
239 t037
CC474/1900 (6) 474 t127, t1186
1900 t127
Singletons (9)d 45 t026, t040, t736
36 t018, t1932
59 t437
88 t5916
188 t189
217 t032
a eBURST (based upon related sequence types) algorithm.
b CC, clonal complex. All members of a CC share identical alleles at six of the seven loci
with at least one other member of the CC.
c Only the three most common spa types are listed if more than three associated with
that sequence type (ST).
d STs with allelic profiles that share less than six of their seven loci with all other STs in
the data set.
MRSA Genetic Diversity in Nursing Homes
November 2013 Volume 51 Number 11 jcm.asm.org 3791
nursing homes collected significantly more t242 isolates, whereas
6 nursing homes (16.7%) collected significantly more t002 isolates
(P  0.05). Two nursing homes collected no t002/t242 isolates
(each collected less than 10 MRSA isolates, and all were t008). The
two nursing homes that isolated significantly more t008 (USA300)
MRSA than t002/t242 (USA100) MRSA are therapeutic residen-
tial centers. Nursing homes with a higher percentage of residents
admitted from a hospital had significantly lower percentages of
t008 isolates (r0.61; P 0.001).
Admission versus point prevalenceMRSA isolates.The over-
all MRSA spa type genetic diversity was not significantly different
among isolates collected at admission (1D 76% [95% CI, 74
to 79%]) versus isolates collected during point prevalence testing
(1 D 77% [95% CI, 75 to 79%]). Within individual nursing
homes, no significant differences in MRSA spa type genetic diver-
sity between admission and point prevalence testing were found
(11 nursing homes were tested, and the 95% confidence intervals
for admission and point prevalence diversity overlapped in all,
indicating nonsignificance; the remaining 14 nursing homes did
not isolate sufficient numbers, and thus, diversity indices could
not be reliably estimated for these). No significant correlation was
found between admission prevalence and the proportion of t008
isolates (r  0.09; P  0.73). The proportions of t008, t002, and
t242 strain types were not significantly different between admis-
sion and point prevalence MRSA isolates (29%, 31%, and 40%
among admission MRSA strains versus 34%, 27% and 39% among
point prevalence MRSA strains, respectively; 2  2.1; df 2; P
0.35).
DISCUSSION
We conducted a prospective collection of carriage isolates of
MRSA from 26 nursing homes in Orange County, California. The
study investigated the frequency and genetic diversity of MRSA in
these little-studied health care facilities to better inform nursing
home-based infection control strategies. This is the first study to
assess MRSA diversity in nursing homes at a population level and
across a large region.
Countywide, nursing home carriage MRSA isolates were dom-
inated in approximately equal proportions by three strains: MLST
and previous PFGE testing of Orange County MRSA isolates iden-
tified these as the predominant, traditionally community-associ-
ated clone in the United States, USA300 (ST8/t008); the tradition-
ally health care-associated clone USA100 (ST5/t002) and ST5/
t242 isolates that likely represent a variant of USA100 that has
become prevalent in health care facilities in Orange County, Cal-
ifornia (29, 30). ST5/t242 isolates were slightly more common
than USA300 and USA100, representing a third of all Orange
County nursing home carriage MRSA isolates. In Orange County
hospitals, the same three strains dominated, but USA300 was the
most common clone (29).
As in hospitals in Orange County, California, most spa types
were closely related to either USA300 or USA100, creating two
FIG 2 Relative proportion of isolates with spa type t008 versus spa types t002/t242, by nursing home. The presence of an asterisk after the total number of t008
and t002/t242 isolates indicates a significant difference at the 95% level in the relative proportion of isolates with spa type t008 and spa types t002/t242 at that
nursing home. The black bars show the point estimates and 95% CIs of nursing home-specific genetic diversity expressed as Simpson’s index of diversity (1D)
of spa types (as a percentage). Diversity indices for nursing homes 15, 18, 22, and 25 were excluded from the figure, as these nursing homes had spa type data on
less than 10 isolates. Diversity indices with nonoverlapping 95% CIs were considered significantly different (P 0.05). The nursing home-specific proportions
of t008 among all spa types have been previously reported (55).
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large, distinct spa-CCs (29). Of the two smaller spa-CCs, one rep-
resented strains of the traditionally CA-MRSA lineage MLST CC1,
with most isolates typed as ST474/t127. ST474 is a single-locus
variant (SLV) of ST1, and ST1/t127 is a common CA-MRSA strain
in the United Kingdom (34). ST474/t127 isolates were also found
among Orange County hospital inpatients, and t127 was also re-
cently reported among U.S. isolates by Hudson et al. (29) and
Tenover et al. (35). The other small spa-CC, spa-CC1932, repre-
sented traditionally HA-MRSA and included the epidemic clone
USA200 (ST36/EMRSA-16) and the pandemic clone ST239.
The isolates that could not be assigned to a spa-CC included
both traditionally health care- and community-associated MRSA
strains. The traditionally health care-associated strains were
USA600/Berlin clone (ST45) and ST217/t032, a SLV of ST22, the
pandemic HA-MRSA clone EMRSA-15 that has also recently been
reported in the community (36). The traditionally community-
associated strains were USA1000 (ST59), ST188 (a double-locus
variant of ST1 and ST474 reported sporadically in Australia and
Asia [37–39]), and ST88, a clone closely related to CC1 that has
been reported in several countries, particularly Nigeria, but has
not been previously reported in the United States (40, 41).
It is clear that USA300 and USA100 dominate health care fa-
cilities in Orange County, California, in line with the MRSA pic-
ture seen nationwide. However, it would be interesting to investi-
gate whether the USA100 t242 variant seen in this county is also
more common than USA100 elsewhere in the United States. t242
has been reported sporadically and was found to be endemic in
one hospital in Italy (42–45).
The overall genetic diversity of MRSA in nursing homes in
Orange County, California, was significantly higher than that seen
in hospitals in Orange County (29). The higher proportion of
traditionally HA-MRSA strains present in nursing homes likely
drives this, which could be a result of the high proportion of res-
idents directly admitted to nursing homes from a number of dif-
ferent Orange County hospitals. Diversity was significantly lower
among spa-CC008 isolates than spa-CC002 isolates. Since spa-
CC002 is largely represented by USA100 and its close spa type
relatives, it can be suggested that MRSA diversity in Orange
County is driven by traditionally health care-associated strains.
In exploratory analyses, greater MRSA genetic diversity was
significantly associated with older resident age and diabetic resi-
dents. Diabetic foot ulcers are a known risk factor for MRSA, and
in particular traditionally HA-MRSA, with MRSA found to be
present in 10 to 30% of diabetic wounds (46–49). Diabetic com-
plications, such as neuropathy, osteomyelitis, and peripheral vas-
cular disease, may result in a prolonged hospital stay, increasing
the exposure of diabetic people to HA-MRSA (46). Older age is a
well-established risk factor for HA-MRSA, as elderly patients tend
to be sicker and require hospital treatment. Older age was a sig-
nificant predictor of genetic diversity in hospitals in Orange
County, California, and was associated with non-t008 strains in a
study comparing adult and pediatric Orange County inpatients
(29, 30).
In Orange County, California, traditionally community-asso-
ciated strains are present in nursing homes but to a lesser extent
than in hospitals (29), with the majority of nursing homes isolat-
ing significantly more MRSA traditionally associated with the
health care setting. The vast majority of residents in this study
were admitted to nursing homes directly from a hospital and thus
were not recently exposed to the community MRSA reservoir,
reducing the likelihood of isolating a traditionally community-
associated strain at nursing home admission. While traditionally
community-associated strains are increasing in hospital settings,
it is likely that many hospitals have two incompletely mixed
MRSA strain populations—a predominantly community-type
MRSA reservoir among patients that came from and will return to
the community, and a predominantly health care-type MRSA res-
ervoir among patients that cycle into longer-term care settings.
The nursing home resident demographic consists of older, sicker
people who generally have a history of health care exposure and
thus tend to have traditionally health care-associated strains,
which are associated with more invasive infections and serious
illness. In addition, the long-term care provided by nursing homes
means that the resident turnover rate in these facilities is far lower
than the patient turnover rate in hospitals. This results in a lower
frequency of possible introductions of MRSA from outside the
health care setting. Nonetheless, traditionally community-associ-
ated strains are penetrating the nursing home MRSA reservoir.
The significantly higher point prevalence of MRSA compared
to admission prevalence may be due to the transmission within
nursing homes of MRSA imported by residents upon admission.
Previous studies of nursing homes in Orange County, California,
found MRSA importation to be a strong predictor of MRSA prev-
alence, with burden and transmission driven by the number of
residents with chronic illnesses or indwelling devices (15, 50).
A limitation of this study was that few individual-level charac-
teristics were available, so facility-level data were primarily used.
We also swabbed only a single site for MRSA. Although nares
screening is thought to detect the majority of MRSA carriers (51,
52), anatomical sites such as the rectum and throat have been
shown to be important in the detection of MRSA carriage (10, 53,
54). In using genetic diversity as the outcome, we reduced the
sample size considerably, and thus multivariate analysis of predic-
tor variables could only be exploratory. Also, the diversity indices
estimated for spa-CC008 isolates versus spa-CC002 isolates may
have been influenced by differing sample sizes (32).
This study was designed to assess the extent of MRSA reservoir
mixing and to examine how this varies across nursing homes
within a single, large U.S. county. The diversity of carriage MRSA
isolates among nursing home residents, although heterogeneous
between facilities, was significantly higher than the diversity
among clinical MRSA isolates from hospital inpatients in the same
county (77% versus 72%) (29). MRSA diversity in both hospitals
and nursing homes appears to be driven by spa types closely re-
lated to those of USA100. The proportions of older, diabetic resi-
dents were significant predictors of nursing home MRSA diver-
sity. When combining data from all nursing homes, we found that
t002/t242 (USA100) and t008 (USA300) isolates dominated this
setting, with ST5/t242 the most prevalent clone. USA300 was the
second most common clone isolated from the nares of nursing
home residents, suggesting substantial penetration of traditionally
community-associated strains into the nursing home reservoir,
but to a lesser extent than seen in hospitals, where USA300 was
predominant. Nursing home MRSA burden appeared to be
largely due to importation of diverse strains from hospitals and
subsequent transmission of these imported strains, leading to high
MRSA point prevalence. Nursing homes therefore represent a sig-
nificant reservoir for MRSA, and as such, a consensual, regionally
implemented control strategy tailored to this unique setting is
required. However, due to the complexity of MRSA control in
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these facilities, further studies evaluating the contribution of nurs-
ing homes to regional MRSA transmission are needed before de-
veloping such a strategy.
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